Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMCQF) Payables (2016 - 2019)

Fresenius Medical Care AG has reported Payables over the past 11 years, most recently at $2.1 billion for Q4 2019.

  • Quarterly results put Payables at $2.1 billion for Q4 2019, down 1.98% from a year ago — trailing twelve months through Dec 2019 was $2.1 billion (down 1.98% YoY), and the annual figure for FY2019 was $2.1 billion, down 1.98%.
  • Payables for Q4 2019 was $2.1 billion at Fresenius Medical Care AG, down from $2.1 billion in the prior quarter.
  • Over the last five years, Payables for FMCQF hit a ceiling of $2.1 billion in Q4 2018 and a floor of $627.8 million in Q4 2015.
  • Median Payables over the past 5 years was $1.6 billion (2017), compared with a mean of $1.5 billion.
  • Biggest five-year swings in Payables: soared 97.35% in 2016 and later fell 1.98% in 2019.
  • Fresenius Medical Care AG's Payables stood at $627.8 million in 2015, then soared by 97.35% to $1.2 billion in 2016, then grew by 28.36% to $1.6 billion in 2017, then surged by 32.52% to $2.1 billion in 2018, then decreased by 1.98% to $2.1 billion in 2019.
  • The last three reported values for Payables were $2.1 billion (Q4 2019), $2.1 billion (Q4 2018), and $1.6 billion (Q4 2017) per Business Quant data.